James E. Dentzer Chief Financial Officer Mr. Dentzer joined Amicus in September 2006 as Chief Financial Officer. He joined the company from Biogen Idec Inc. where he served as Corporate Controller from November 2003 to September 2006. ir.amicustherapeutics
Amicus Therapeutics is a biopharmaceutical company developing a new class of drugs called pharmacological chaperones to treat a range of human genetic diseases in which crucial proteins are misfolded. www.amicustherapeutics.com/about/mgmt.asp
